Promising
Ergothioneine
The prediction game
Call it: rising or fading?
Where does Ergothioneine stand 12 months from now? Lock your call with a confidence level. When the window closes, the Brier rule scores your calibration: right and confident earns the most, wrong and confident costs the most. Points and a leaderboard spot are the whole prize. No stakes, no money.
One call per intervention. It locks the moment you submit: no edits, no cancels. It resolves when the 12-month window closes.
The Crowd’s Call
Rising or fading over the next 12 months? Lock your call and find out if you saw it coming.
Community Signal
No weigh-ins yet. Be the first and set the early signal.
Evidence
Evidence grade: D (early evidence)
Graded from the strength of the published research, independent of any verdict on this page.
Evidence Anchor
BioHarmony 6.6/10
Ergothioneine is a 6.6 out of 10 fit for the longevity-minded person who eats few mushrooms and wants a cheap, very safe, tissue-retained antioxidant while the human outcome trials catch up to the biology. The case rests on an exceptional mechanism and the Smith et al. 2020 cohort, where higher plasma levels tracked with 21% lower cardiovascular mortality over two decades, balanced against the honest reality that only two small interventional trials exist and one was industry-funded. That makes ergothioneine a sensible long-game hedge for a defined reader, and a poor choice for anyone expecting a felt effect or treating it as a substitute for proven care. In practice it belongs after the basics, alongside a mushroom-rich diet, with your own lipids and inflammation tracked so you judge it by your numbers rather than the hype. ✅ Best for: Adults over 60, whose blood ergothioneine has naturally declined, who want a low-risk antioxidant hedge. People who rarely eat mushrooms and therefore run low on dietary intake. Longevity enthusiasts who want a cheap, very safe foundational nutrient with a genuine transporter-backed mechanism. Anyone with a strong family history of cardiovascular disease who is already doing the established things and wants a well-tolerated adjunct they can track. Pragmatic biohackers comfortable making a plausible long-game bet on strong biology while honestly acknowledging the interventional evidence is still maturing. ❌ Avoid if: You are pregnant or breastfeeding, since supplement-dose safety is not established, though dietary mushrooms are fine. You expect a noticeable acute or short-term effect, because there is none. You would use it in place of proven cardiovascular or cognitive care, which the association data in Smith et al. 2020 does not support. You already eat mushrooms several times a week and likely carry ample stores. You have a known mushroom allergy and are considering mushroom-extract sources rather than purified fermentation-derived material.
Read the full BioHarmony report
My score and my verdict: one signal of three, never the whole answer.
Momentum
Signals begin with Edition 2
Direction needs two weekly snapshots to compare, so the arrows stay off until the next edition. Attention tracking is already running.
Momentum = how fast attention is rising across search, Reddit, PubMed, podcasts, and curated industry newsletters this week; it can flag an item as Overhyped/Fading, but it never overrides the evidence behind Proven. How momentum works.
- Ring
- Promising
- Trend
- Begins with Edition 2
- Momentum
- 6.7%
- BioHarmony Score
- 6.6/10
- Last Updated
- Jul 2, 2026
Sources
- BioHarmony score
- Search trend delta
- Reddit velocity
- PubMed publication count
- Podcast mention frequency
- Curated newsletter mentions
The score anchors the ring; the other five drive momentum, which can nudge the ring by one step at most. How placement works.
Weigh In
Your input feeds the community signal shown beside my verdict. It informs the board and it never sets the score by itself. How community input works.
New voice here? We send a one-tap verification link so every entry comes from a real person. Signed-in members skip this.